Thursday, October 15, 2026

Custom AI Chip Orders Surge as Marvell, AMD Target Cloud Providers Across Three Continents

Marvell Technology and AMD are accelerating custom AI chip development for data centers as cloud providers in North America, Europe, and Asia seek specialized processors beyond general-purpose GPUs. Asian manufacturers LG Innotek and Samsung Electro-Mechanics race to commercialize glass substrate technology for advanced packaging. U.S. defense regulations banning Chinese rare earth materials from 2027 are forcing global semiconductor supply chain diversification.

LM Salvado
LM Salvado

March 22, 2026

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
Custom AI Chip Orders Surge as Marvell, AMD Target Cloud Providers Across Three Continents
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Marvell Technology is expanding custom chip development for data centers as enterprise clients across North America, Europe, and Asia increase AI tool adoption.1 Cloud providers are moving beyond general-purpose GPUs toward application-specific integrated circuits for machine learning workloads, with AMD and other chipmakers joining the custom processor race.

Asian manufacturers are competing to commercialize glass substrate technology for advanced chip packaging. LG Innotek and Samsung Electro-Mechanics are developing substrates that enable higher density interconnects and improved thermal management for AI accelerators, targeting cloud infrastructure operators worldwide.

Samsung Electronics set a 2027 target for fully autonomous network systems while deploying its Snapdragon 8 Elite Gen 5 processor in the Galaxy S26 Ultra.2 The company integrated satellite communication across Galaxy flagship and A-series devices starting in 2025, expanding connectivity for edge AI applications globally.2 Samsung introduced Privacy Display technology, marketed as the first built-in privacy screen for mobile devices.2

U.S. defense regulations are reshaping global semiconductor supply chains. Starting 2027, Chinese rare earth materials will be banned from defense systems, forcing manufacturers worldwide to diversify sourcing.1 Micron is responding by expanding domestic U.S. manufacturing capacity, reflecting broader industry shifts toward geographically distributed production networks.

The semiconductor sector faces dual pressures: surging demand for specialized AI acceleration hardware and geopolitical requirements for supply chain resilience. Companies are balancing performance requirements with regulatory compliance as international trade policies evolve.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]Press releaseGlobeNewswire· March 2, 2026
    AMD Gives Consumers and Businesses More AI PC Options with Expanded Ryzen™ AI 400 Series Portfolio
  2. [2]News articleYahoo Finance· March 1, 2026
    Linux Foundation Announces OCUDU Ecosystem Foundation to Accelerate Open Source AI-RAN Innovation
  3. [3]News articleYahoo Finance· March 3, 2026
    Samsung Advances Galaxy AI and Its Connected Ecosystem at MWC 2026
  4. [4]News articleYahoo Finance· March 6, 2026
    Stock market today: Dow, S&P 500, Nasdaq sink after jobs report surprise as oil jumps
  5. [5]News articleNasdaq· March 6, 2026
    Stocks Retreat Amid Inflation Fears and Weak US Jobs
  6. [6]News articleNasdaq· March 6, 2026
    Stocks Retreat on Inflation Concerns and a Weak US Job Market
  7. [7]News articleNasdaq· March 3, 2026
    Stocks Tumble as Crude Oil Soars and Bond Yields Rise
  8. [8]News articleYahoo Finance· March 16, 2026
    Synopsys Showcases NVIDIA Partnership Impact and Ecosystem Innovation at GTC 2026
  9. [9]News articleYahoo Finance· November 26, 2025
    AI to Reshape the Global Technology Landscape in 2026, Says TrendForce
  10. [10]News articleYahoo Finance· March 19, 2026
    A New U.S. Facility Could Break China’s Grip on Critical Materials
  11. [11]News articleYahoo Finance· February 2, 2026
    Aptiv (APTV) Q4 2025 Earnings Call Transcript
  12. [12]News articleYahoo Finance· January 30, 2026
    MaxLinear (MXL) Q4 2025 Earnings Call Transcript

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com